Merck Chairman and CEO Robert Davis joins 'Mad Money' host Jim Cramer at the JPMorgan Healthcare Conference to talk recent ...

Mad Money' host Jim Cramer looks at several healthcare stocks and shares his perspective on their trajectory in 2025.

We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soared. In this article, we are ...

We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soared. In this article, we are ...

Jim Cramer is steering investors toward quantum computing stocks while expressing concerns about Super Micro Computer Inc.

CNBC’s Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and ...

We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soared. In this article, we are ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

Merck CEO Rob Davis told CNBC’s Jim Cramer that there’s more to the pharmaceutical giant than its lucrative cancer drug, Keytruda.

Sen. Kaine was the first Virginia senator to publicly question a Trump nominee, ahead of the president-elect's second ...

Donald Trump’s cabinet picks are beginning their nomination process this week, starting with Trump’s choice for defense secretary, Pete Hegseth ...